Literature DB >> 32262838

Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications.

Gabriele Sponchia1, Emmanuele Ambrosi, Flavio Rizzolio, Mohamad Hadla, Anna Del Tedesco, Concetta Russo Spena, Giuseppe Toffoli, Pietro Riello, Alvise Benedetti.   

Abstract

Nanocarriers as theranostic agents are under the spotlight in modern nanomedicine, and mesoporous nanomaterials represent a class of devices of major interest. Zirconia is biocompatible, inert with good mechanical and thermal properties for in vivo biomedical applications. Although a few examples of zirconia nanoparticles have been described, a major limitation was the low surface area, which is fundamental for payload transport. Here, a simple and highly efficient method is described for the synthesis of spherical mesoporous zirconia nanoparticles (MZNs) with a high surface area through a neutral surfactant-assisted sol-gel method. The combination of alkali halides and vacuum extraction allowed stabilization of the shape and size of MZNs and to avoid porous network failure, respectively. In comparison to published synthesis procedures, a high surface area has been obtained. Biological experiments demonstrated that MZNs were biocompatible, cell permeable and degradable providing a proof of concept for theranostic applications. A comparison with the properties of mesoporous silica nanoparticles has also been performed.

Entities:  

Year:  2015        PMID: 32262838     DOI: 10.1039/c5tb01424g

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  1 in total

1.  Modification of Amorphous Mesoporous Zirconia Nanoparticles with Bisphosphonic Acids: A Straightforward Approach for Tailoring the Surface Properties of the Nanoparticles.

Authors:  Khohinur Hossain; Luca Florean; Anna Del Tedesco; Elti Cattaruzza; Marco Geppi; Silvia Borsacchi; Patrizia Canton; Alvise Benedetti; Pietro Riello; Alessandro Scarso
Journal:  Chemistry       Date:  2021-11-17       Impact factor: 5.020

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.